Related Experiment Videos
Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation
A M Brunati1, L A Pinna, E Bergantino
1Dipartimento di Chimica Biologica, Universita' di Padova, Italy.
Abstract:
The SH2 domain of c-Fgr (class 1A) has been expressed in E. coli as GST fusion protein and tested for its ability to prevent the dephosphorylation of a variety of phosphotyrosyl (poly)peptides by three distinct protein tyrosine phosphatases (TC-PTPase, YOP, and Low Mr PTPase). Dephosphorylation of HS1 protein and of a derived phosphopeptide, HS1 (388-402), exhibiting the motif selected by class 1A SH2 domains is inhibited in a dose dependent manner with full inhibition promoted by a 2- to 3-molar excess of GST/SH2 domain irrespective of either the nature or the amount of phosphatase used. The IC50 values for inhibition of these and other phosphotyrosyl substrates roughly correlates with their expected affinity for class 1A SH2 domain. Inhibition is partially reversed by the addition of D-myo-inositol 1,4,5-triphosphate, which competes for the binding to the SH2 domains. Our data on one side show that additional mechanism(s) besides mere competition must assist PTPases to dissociate SH2-PTyr complexes and on the other suggest a role for SH2 domains in protecting phosphotyrosyl residues from premature dephosphorylation.
Insights
The SH2 domain of c-Fgr protein inhibits protein tyrosine phosphatases, protecting phosphotyrosyl peptides from dephosphorylation. This suggests SH2 domains play a role in maintaining protein phosphorylation signaling pathways.
Area of Science:
- Biochemistry
- Molecular Biology
- Signal Transduction
Background:
- SH2 domains are crucial protein modules that bind to phosphotyrosine residues.
- Protein tyrosine phosphatases (PTPases) remove phosphate groups from tyrosine residues, regulating signaling pathways.
- Dysregulation of PTPase activity is implicated in various diseases, including cancer.
Purpose of the Study:
- To investigate the inhibitory potential of the c-Fgr SH2 domain on PTPase activity.
- To determine the mechanism by which SH2 domains interact with PTPases and their substrates.
- To explore the role of SH2 domains in protecting phosphotyrosine sites from dephosphorylation.
Main Methods:
- Expression and purification of the c-Fgr SH2 domain as a GST fusion protein in E. coli.
- In vitro assays to measure PTPase activity using various phosphotyrosyl peptides and proteins.
- Dose-response inhibition studies and determination of IC50 values.
- Competition assays using D-myo-inositol 1,4,5-triphosphate.
Main Results:
- The c-Fgr SH2 domain potently inhibited the dephosphorylation of phosphotyrosyl peptides and proteins by multiple PTPases.
- Inhibition was dose-dependent, with maximal effect observed at a 2- to 3-molar excess of the SH2 domain.
- Inhibition efficacy correlated with the expected binding affinity of substrates for the SH2 domain.
- D-myo-inositol 1,4,5-triphosphate partially reversed the inhibition, indicating competitive binding.
Conclusions:
- SH2 domains can directly inhibit PTPase activity, suggesting a regulatory mechanism beyond simple substrate competition.
- Additional mechanisms, besides direct competition, are involved in PTPase-SH2-phosphotyrosine complex dissociation.
- SH2 domains play a protective role in preventing premature dephosphorylation of phosphotyrosine residues, thereby stabilizing signaling events.